Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Hematologic Condition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01166009
What this trial is testing

CIBMTR Research Database

Who this might be right for
Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationSolid Tumors+4 more
Center for International Blood and Marrow Transplant Research 99,999,999
Testing effectiveness (Phase 2)UnknownNCT00008307
What this trial is testing

Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Herbert Irving Comprehensive Cancer Center 52
Not applicableStudy completedNCT00142155
What this trial is testing

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 300
Large-scale testing (Phase 3)Study completedNCT00364260
What this trial is testing

A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.

Who this might be right for
AnemiaKidney FailureLeft Ventricular Hypertrophy
Janssen-Ortho Inc., Canada 172
Large-scale testing (Phase 3)Study completedNCT01507896
What this trial is testing

BAX 326 Surgery Study in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Early research (Phase 1)Temporarily pausedNCT06514261
What this trial is testing

Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 45
Not applicableUnknownNCT05050851
What this trial is testing

Nutritional Parameters and Other Risk Factors Affecting Severity of Pneumonia in Children Under Five Years in Upper Egypt

Who this might be right for
HypoalbuminemiaStunted GrowthAnemia, Iron Deficiency
Assiut University 30
Post-approval studies (Phase 4)Study completedNCT00199082
What this trial is testing

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

Who this might be right for
Burkitt's LymphomaBurkitt's LeukemiaMediastinal Neoplasms+2 more
Nicola Goekbuget 650
Testing effectiveness (Phase 2)Study completedNCT00382590
What this trial is testing

Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00014495
What this trial is testing

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT00171912
What this trial is testing

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Who this might be right for
Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more
Novartis Pharmaceuticals 38
Testing effectiveness (Phase 2)Looking for participantsNCT05776069
What this trial is testing

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

Who this might be right for
Von Willebrand Diseases
Vega Therapeutics, Inc 116
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT03483324
What this trial is testing

Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia in RemissionMyelodysplastic Syndromes+1 more
Angiocrine Bioscience 10
Early research (Phase 1)Study completedNCT00743028
What this trial is testing

Assess the Oral Bioavailability of New ABT-263 Formulations

Who this might be right for
Chronic Lymphocytic LeukemiaLymphomasLeukemias
Abbott 36
Not applicableUnknownNCT05530239
What this trial is testing

Nano-rheological Biomarkers for Patients With Sickle Cell Disease (SCD) Versus Control Subjects (Other Constitutional Red Blood Cell Diseases and Healthy Subjects)

Who this might be right for
Sickle Cell Disease
University Hospital, Grenoble 40
Not applicableLooking for participantsNCT03555851
What this trial is testing

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

Who this might be right for
Leukemia, Not Otherwise SpecifiedLeukemia, Other
Wake Forest University Health Sciences 120
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Large-scale testing (Phase 3)Looking for participantsNCT06152575
What this trial is testing

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Who this might be right for
Multiple Myeloma
Pfizer 492
Not applicableStudy completedNCT00674193
What this trial is testing

Evaluating Dactinomycin and Vincristine in Young Patients With Cancer

Who this might be right for
Childhood Acute Lymphoblastic LeukemiaChildhood RhabdomyosarcomaChildhood Soft Tissue Sarcoma+5 more
Children's Oncology Group 158
Next Page